Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression.

ABSTRACT:

SUBMITTER: Gaffney K 

PROVIDER: S-EPMC6269317 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature